Life Stem Genetics Announces Collaborative Agreement with American CryoStem

(Stem Cells News image)

Image representing American CryoStem as depict...

 

Life Stem Genetics announced today a strategic collaborative agreement with American CryoStem Corporation.

 

CRYO is a leading developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries.

 

Adipose tissue is an anatomical term for loose connective tissue (fat) composed of adipocytes (cells). It is used in LIFS stem cell procedures and currently is extracted via liposuction each time a patient has a treatment.

 

This collaboration will give our physician‘s network the ability to store a patient’s adipose tissue for future regenerative medicine applications after only one extraction process. In the absence of future liposuction procedures, the patient’s recovery time is lessened and additional procedure costs are reduced.

 

This collaboration will provide the Company’s physicians and medical clinics access to a FDA registered laboratory and the science of tissue collection, processing and long term storage of their patient’s adipose tissue sample collected at the point of care.

 

American CryoStem’s ATGRAFT(TM) tissue samples are processed and prepared upon arrival at their FDA registered laboratory based in Mt. Laurel, N.J., tested for adipocyte and cellular viability, and stored free of charge for six months. Long term storage fees will be billed directly to the patient by American CryoStem with revenue shared with LIFS. Stored patient samples retrieved by LIFS physicians will be shipped, ready for use without any additional processing.

 

Life Stem Genetics Chief Medical Stem Cell Specialist, James Vanden Bosch, BHA, commented, “This relationship secured with American CryoStem by Life Stem Genetics advances our physician’s treatment protocols from traditionally collecting and processing patients adipose tissue in the same day to establishing a treatment program not dictated by a single liposuction procedure.” Mr. Vanden Bosch further commented, “Patients can now visit a clinic and have future treatments with the same high quality adipose tissue.” he adds.

 

from:goo.gl/fPqCSM

 

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.